Order Article Reprints

Mostafa A, Kandeil A, A. M. M. Elshaier Y, Kutkat O, Moatasim Y, Rashad AA, Shehata M, Gomaa MR, Mahrous N, Mahmoud SH, et al. FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2. Pharmaceuticals. 2020; 13(12):443. https://doi.org/10.3390/ph13120443

Mostafa, Ahmed, Ahmed Kandeil, Yaseen A. M. M. Elshaier, Omnia Kutkat, Yassmin Moatasim, Adel A. Rashad, Mahmoud Shehata, Mokhtar R. Gomaa, Noura Mahrous, Sara H. Mahmoud, and et al. 2020. "FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2" Pharmaceuticals 13, no. 12: 443. https://doi.org/10.3390/ph13120443

Mostafa, A., Kandeil, A., A. M. M. Elshaier, Y., Kutkat, O., Moatasim, Y., Rashad, A. A., Shehata, M., Gomaa, M. R., Mahrous, N., Mahmoud, S. H., GabAllah, M., Abbas, H., Taweel, A. E., Kayed, A. E., Kamel, M. N., Sayes, M. E., Mahmoud, D. B., El-Shesheny, R., Kayali, G., & Ali, M. A. (2020). FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2. Pharmaceuticals, 13(12), 443. https://doi.org/10.3390/ph13120443